Finance

Beta
Lists
DAP:FRA
Danaher Corp
€153.70
-1.19%
(-1.85) 1D
Jun 2, 12:31:14 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DAP...
Open
€153.80
High
€154.80
Low
€153.70
Mkt. cap
127.31B
Avg. vol.
574.00
Volume
223.00
52-wk high
€208.30
52-wk low
€137.80
No. of employees
59K
Open
€153.80
High
€154.80
Low
€153.70
Mkt. cap
127.31B
Avg. vol.
574.00
Volume
223.00
52-wk high
€208.30
52-wk low
€137.80
No. of employees
59K
News stories
From sources across the web
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees59K
Founded1969
Headquarters-
SectorHealth care
Websitedanaher.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.94B
6.05B
6.84B
5.95B
Cost of goods sold
2.41B
2.53B
2.86B
2.36B
Cost of revenue
2.41B
2.53B
2.86B
2.36B
Research and development expenses
403.00M
378.00M
438.00M
387.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93B
1.89B
2.03B
1.84B
Operating expense
2.33B
2.27B
2.46B
2.23B
Total operating expenses
4.74B
4.80B
5.32B
4.59B
Operating income
1.19B
1.26B
1.52B
1.36B
Other non operating income
-
-
-87.00M
-
EBT including unusual items
655.00M
1.08B
1.37B
1.24B
EBT excluding unusual items
1.13B
1.19B
1.39B
1.33B
Income tax expense
100.00M
168.00M
190.00M
206.00M
Effective tax rate
15.27%
15.61%
13.84%
16.68%
Other operating expenses
-
-
-
-
Net income
555.00M
908.00M
1.20B
1.03B
Net profit margin
9.35%
15.00%
17.51%
17.29%
Earnings per share
1.80
1.89
2.23
2.06
Interest and investment income
8.00M
3.00M
13.00M
27.00M
Interest expense
-71.00M
-67.00M
-55.00M
-63.00M
Net interest expenses
-63.00M
-64.00M
-42.00M
-36.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.80B
1.88B
2.14B
1.99B
Gain or loss from assets sale
-81.00M
-9.00M
9.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer